Article Details
Retrieved on: 2024-03-08 18:25:55
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the biotech industry's growth prospects in finance, particularly looking at companies like Gilead Sciences and Sarepta Therapeutics, which may benefit from predicted earnings growth due to an expected low interest rate environment.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here